Skip to content

Study · Animal study (in vivo) · goldfish (carassius auratus) · 2005

2 results

Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.

Matsuda K, Maruyama K, Nakamachi T, Miura T, Uchiyama M, Shioda S

Peptides11 Apr 2005Cited by 70 (Europe PMC)

PMID16112400 (opens in a new tab)DOI10.1016/j.peptides.2005.02.022 (opens in a new tab)PepBankPUB-16112400
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In goldfish, intracerebroventricular VIP at 11 or 22 pmol/g significantly decreased cumulative food intake over 60 minutes.

    In plain wordsIn goldfish, VIP injected into the brain reduced the amount of food eaten.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    DecreaseCumulative food intake
    Study

    goldfish (Carassius auratus)n: not reported in source

    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    11 or 22 pmol/g body weight · intracerebroventricularAs given in this study (goldfish (Carassius auratus)).

    Source sentences

    Summary
    Cumulative food intake was significantly decreased by ICV injection of PACAP (11 or 22 pmol/g body weight) or VIP (11 or 22 pmol/g) during a 60-min observation period after treatment.
    1 context sentence
    Summary · context
    Therefore, we investigated the effects of intracerebroventricular (ICV) and intraperitoneal (IP) administration of synthetic PACAP and VIP on food intake in the goldfish, Carassius auratus.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In goldfish, intraperitoneal VIP at 22 or 44 pmol/g significantly decreased food intake over 60 minutes.

    In plain wordsIn goldfish, VIP injected into the belly cavity reduced the amount of food eaten.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    DecreaseCumulative food intake
    Study

    goldfish (Carassius auratus)n: not reported in source

    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    22 or 44 pmol/g · intraperitonealAs given in this study (goldfish (Carassius auratus)).

    Source sentences

    Summary
    IP administration of PACAP (44 or 88 pmol/g) or VIP (22 or 44 pmol/g) induced a significant decrease in food intake during a 60-min observation period after treatment.
    1 context sentence
    Summary · context
    Therefore, we investigated the effects of intracerebroventricular (ICV) and intraperitoneal (IP) administration of synthetic PACAP and VIP on food intake in the goldfish, Carassius auratus.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.